 | • レポートコード：20QY06-04249 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ラタノプロストのグローバル市場について種類別（ブランド医薬品、ジェネリック医薬品）、用途別（オープンアングル緑内障、クローズアングル緑内障）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ラタノプロスト市場の概要 ・世界の主要地域別ラタノプロスト市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のラタノプロスト市場規模2015-2026：種類別（ブランド医薬品、ジェネリック医薬品） ・世界のラタノプロスト市場規模2015-2026：用途別（オープンアングル緑内障、クローズアングル緑内障） ・ラタノプロストの北米市場規模2015-2020 ・ラタノプロストのヨーロッパ市場規模2015-2020 ・ラタノプロストの中国市場規模2015-2020 ・ラタノプロストの日本市場規模2015-2020 ・ラタノプロストの東南アジア市場規模2015-2020 ・ラタノプロストのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Pfizer、Mylan、Novartis、Apotex、Teva、Taj Pharma、CR Zizhu） ・ラタノプロストの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ラタノプロストの市場動向・機会・課題 ・調査の結論 |
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is widely used in the treatment of Open-angle Glaucoma and Closed-angle Glaucoma. The most proportion of Latanoprost is Open-angle Glaucoma, and the sales market share in 2016 is about 82%.
Market Analysis and Insights: Global Latanoprost Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Latanoprost market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Latanoprost industry.
Based on our recent survey, we have several different scenarios about the Latanoprost YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 1313.4 million in 2019. The market size of Latanoprost will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Latanoprost Scope and Market Size
The global Latanoprost market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Latanoprost market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Latanoprost market is segmented into
Brand Drug
Generic Drug
Segment by Application, the Latanoprost market is segmented into
Open-angle Glaucoma
Close-angle Glaucoma
The Latanoprost market is analysed and market size information is provided by regions (countries). Segment by Application, the Latanoprost market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Latanoprost Market Share Analysis
Latanoprost market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Latanoprost business, the date to enter into the Latanoprost market, Latanoprost product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
…
1 Latanoprost Market Overview
1.1 Latanoprost Product Scope
1.2 Latanoprost Segment by Type
1.2.1 Global Latanoprost Sales by Type (2020-2026)
1.2.2 Brand Drug
1.2.3 Generic Drug
1.3 Latanoprost Segment by Application
1.3.1 Global Latanoprost Sales Comparison by Application (2020-2026)
1.3.2 Open-angle Glaucoma
1.3.3 Close-angle Glaucoma
1.4 Latanoprost Market Estimates and Forecasts (2015-2026)
1.4.1 Global Latanoprost Sales Growth Rate (2015-2026)
1.4.2 Global Latanoprost Revenue and Growth Rate (2015-2026)
1.4.3 Global Latanoprost Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Latanoprost Industry Impact
1.5.1 How the Covid-19 is Affecting the Latanoprost Industry
1.5.1.1 Latanoprost Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Latanoprost Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Latanoprost Players to Combat Covid-19 Impact
2 Latanoprost Estimate and Forecast by Region
2.1 Global Latanoprost Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Latanoprost Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Latanoprost Sales Market Share by Region (2015-2020)
2.2.2 Global Latanoprost Revenue Market Share by Region (2015-2020)
2.3 Global Latanoprost Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Latanoprost Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Latanoprost Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Latanoprost Estimates and Projections (2015-2026)
2.4.2 Europe Latanoprost Estimates and Projections (2015-2026)
2.4.3 China Latanoprost Estimates and Projections (2015-2026)
2.4.4 Japan Latanoprost Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Latanoprost Estimates and Projections (2015-2026)
2.4.6 India Latanoprost Estimates and Projections (2015-2026)
3 Global Latanoprost Competition Landscape by Players
3.1 Global Top Latanoprost Players by Sales (2015-2020)
3.2 Global Top Latanoprost Players by Revenue (2015-2020)
3.3 Global Latanoprost Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Latanoprost as of 2019)
3.4 Global Latanoprost Average Price by Company (2015-2020)
3.5 Manufacturers Latanoprost Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Latanoprost Players (Opinion Leaders)
4 Global Latanoprost Market Size by Type
4.1 Global Latanoprost Historic Market Review by Type (2015-2020)
4.1.1 Global Latanoprost Sales Market Share by Type (2015-2020)
4.1.2 Global Latanoprost Revenue Market Share by Type (2015-2020)
4.1.3 Global Latanoprost Price by Type (2014-2020)
4.2 Global Latanoprost Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Latanoprost Sales Forecast by Type (2021-2026)
4.2.2 Global Latanoprost Revenue Forecast by Type (2021-2026)
4.2.3 Global Latanoprost Price Forecast by Type (2021-2026)
5 Global Latanoprost Market Size by Application
5.1 Global Latanoprost Historic Market Review by Application (2015-2020)
5.1.1 Global Latanoprost Sales Market Share by Application (2015-2020)
5.1.2 Global Latanoprost Revenue Market Share by Application (2015-2020)
5.1.3 Global Latanoprost Price by Application (2015-2020)
5.2 Global Latanoprost Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Latanoprost Sales Forecast by Application (2021-2026)
5.2.2 Global Latanoprost Revenue Forecast by Application (2021-2026)
5.2.3 Global Latanoprost Price Forecast by Application (2021-2026)
3 North America Latanoprost Market Facts & Figures
3.2 North America Latanoprost Sales Market Share by Company (2015-2020)
3.3 North America Latanoprost Sales Market Share by Type (2015-2020)
3.4 North America Latanoprost Sales Market Share by Application (2015-2020)
4 Europe Latanoprost Market Facts & Figures
4.2 Europe Latanoprost Sales Market Share by Company (2015-2020)
4.3 Europe Latanoprost Sales Market Share by Type (2015-2020)
4.4 Europe Latanoprost Sales Market Share by Application (2015-2020)
5 China Latanoprost Market Facts & Figures
5.2 China Latanoprost Sales Market Share by Company (2015-2020)
5.3 China Latanoprost Sales Market Share by Type (2015-2020)
5.4 China Latanoprost Sales Market Share by Application (2015-2020)
6 Japan Latanoprost Market Facts & Figures
6.2 Japan Latanoprost Sales Market Share by Company (2015-2020)
6.3 Japan Latanoprost Sales Market Share by Type (2015-2020)
6.4 Japan Latanoprost Sales Market Share by Application (2015-2020)
7 Southeast Asia Latanoprost Market Facts & Figures
7.2 Southeast Asia Latanoprost Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Latanoprost Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Latanoprost Sales Market Share by Application (2015-2020)
8 India Latanoprost Market Facts & Figures
8.2 India Latanoprost Sales Market Share by Company (2015-2020)
8.3 India Latanoprost Sales Market Share by Type (2015-2020)
8.4 India Latanoprost Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Latanoprost Business
12.1 Pfizer
12.1.1 Pfizer Latanoprost Corporation Information
12.1.2 Pfizer Latanoprost Business Overview and Total Revenue
12.1.3 Pfizer Latanoprost Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Latanoprost Products Offered
12.1.5 Pfizer Recent Development
12.2 Mylan
12.2.1 Mylan Latanoprost Corporation Information
12.2.2 Mylan Latanoprost Business Overview and Total Revenue
12.2.3 Mylan Latanoprost Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Mylan Latanoprost Products Offered
12.2.5 Mylan Recent Development
12.3 Novartis
12.3.1 Novartis Latanoprost Corporation Information
12.3.2 Novartis Latanoprost Business Overview and Total Revenue
12.3.3 Novartis Latanoprost Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Latanoprost Products Offered
12.3.5 Novartis Recent Development
12.4 Apotex
12.4.1 Apotex Latanoprost Corporation Information
12.4.2 Apotex Latanoprost Business Overview and Total Revenue
12.4.3 Apotex Latanoprost Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Apotex Latanoprost Products Offered
12.4.5 Apotex Recent Development
12.5 Teva
12.5.1 Teva Latanoprost Corporation Information
12.5.2 Teva Latanoprost Business Overview and Total Revenue
12.5.3 Teva Latanoprost Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Teva Latanoprost Products Offered
12.5.5 Teva Recent Development
12.6 Taj Pharma
12.6.1 Taj Pharma Latanoprost Corporation Information
12.6.2 Taj Pharma Latanoprost Business Overview and Total Revenue
12.6.3 Taj Pharma Latanoprost Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Taj Pharma Latanoprost Products Offered
12.6.5 Taj Pharma Recent Development
12.7 CR Zizhu
12.7.1 CR Zizhu Latanoprost Corporation Information
12.7.2 CR Zizhu Latanoprost Business Overview and Total Revenue
12.7.3 CR Zizhu Latanoprost Sales, Revenue and Gross Margin (2015-2020)
12.7.4 CR Zizhu Latanoprost Products Offered
12.7.5 CR Zizhu Recent Development
…
13 Latanoprost Manufacturing Cost Analysis
13.1 Latanoprost Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Latanoprost
13.4 Latanoprost Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Latanoprost Distributors List
14.3 Latanoprost Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Latanoprost Sales (M Unit) Growth Rate by Type (2020-2026)
Table 2. Global Latanoprost Sales (M Unit) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Latanoprost Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Latanoprost Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Latanoprost Players to Combat Covid-19 Impact
Table 8. Global Market Latanoprost Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Latanoprost Sales (M Unit) by Region (2015-2020)
Table 10. Global Latanoprost Sales Market Share by Region (2015-2020)
Table 11. Global Latanoprost Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Latanoprost Revenue Share by Region (2015-2020)
Table 13. Global Latanoprost Sales (M Unit) Forecast by Region (2021-2026)
Table 14. Global Latanoprost Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Latanoprost Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Latanoprost Revenue Share Forecast by Region (2021-2026)
Table 17. Global Latanoprost (M Unit) of Key Companies (2015-2020)
Table 18. Global Latanoprost Sales Share by Company (2015-2020)
Table 19. Global Latanoprost Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Latanoprost Revenue Share by Company (2015-2020)
Table 21. Global Latanoprost by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Latanoprost as of 2019)
Table 22. Global Latanoprost Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Latanoprost Manufacturing Sites and Area Served
Table 24. Manufacturers Latanoprost Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Latanoprost Players
Table 27. Global Latanoprost Sales (M Unit) by Type (2015-2020)
Table 28. Global Latanoprost Sales Share by Type (2015-2020)
Table 29. Global Latanoprost Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Latanoprost Price (M Unit) by Type (2015-2020)
Table 31. Global Latanoprost Sales Share by Type (2021-2026)
Table 32. Global Latanoprost Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Latanoprost Revenue Share by Type (2021-2026)
Table 34. Global Latanoprost Price (M Unit) by Type (2021-2026)
Table 35. Global Latanoprost Sales (M Unit) by Application (2015-2020)
Table 36. Global Latanoprost Sales Share by Application (2015-2020)
Table 37. Global Latanoprost Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Latanoprost Price (M Unit) by Application (2015-2020)
Table 39. Global Latanoprost Sales (M Unit) by Application (2021-2026)
Table 40. Global Latanoprost Sales Share by Application (2021-2026)
Table 41. Global Latanoprost Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Latanoprost Revenue Share by Application (2021-2026)
Table 43. Global Latanoprost Price (M Unit) by Application (2021-2026)
Table 44. United States Latanoprost Sales (M Unit) by Company (2015-2020)
Table 45. United States Latanoprost Sales Market Share by Company (2015-2020)
Table 46. United States Latanoprost Sales (M Unit) by Type (2015-2020)
Table 47. United States Latanoprost Sales Market Share by Type (2015-2020)
Table 48. United States Latanoprost Sales (M Unit) by Application (2015-2020)
Table 49. United States Latanoprost Sales Market Share by Application (2015-2020)
Table 50. Europe Latanoprost Sales (M Unit) by Company (2015-2020)
Table 51. Europe Latanoprost Sales Market Share by Company (2015-2020)
Table 52. Europe Latanoprost Sales (M Unit) by Type (2015-2020)
Table 53. Europe Latanoprost Sales Market Share by Type (2015-2020)
Table 54. Europe Latanoprost Sales (M Unit) by Application (2015-2020)
Table 55. Europe Latanoprost Sales Market Share by Type (2015-2020)
Table 56. China Latanoprost Sales (M Unit) by Company (2015-2020)
Table 57. China Latanoprost Sales Market Share by Company (2015-2020)
Table 58. China Latanoprost Sales (M Unit) by Type (2015-2020)
Table 59. China Latanoprost Sales Market Share by Type (2015-2020)
Table 60. China Latanoprost Sales (M Unit) by Application (2015-2020)
Table 61. China Latanoprost Sales Market Share by Application (2015-2020)
Table 62. Japan Latanoprost Sales (M Unit) by Company (2015-2020)
Table 63. Japan Latanoprost Sales Market Share by Company (2015-2020)
Table 64. Japan Latanoprost Sales (M Unit) by Type (2015-2020)
Table 65. Japan Latanoprost Sales Market Share by Type (2015-2020)
Table 66. Japan Latanoprost Sales (M Unit) by Application (2015-2020)
Table 67. Japan Latanoprost Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Latanoprost Sales (M Unit) by Company (2015-2020)
Table 69. Southeast Asia Latanoprost Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Latanoprost Sales (M Unit) by Type (2015-2020)
Table 71. Southeast Asia Latanoprost Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Latanoprost Sales (M Unit) by Type (2015-2020)
Table 73. Southeast Asia Latanoprost Sales Market Share by Application (2015-2020)
Table 74. India Latanoprost Sales (M Unit) by Company (2015-2020)
Table 75. India Latanoprost Sales Market Share by Company (2015-2020)
Table 76. India Latanoprost Sales (M Unit) by Type (2015-2020)
Table 77. India Latanoprost Sales Market Share by Type (2015-2020)
Table 78. India Latanoprost Sales (M Unit) by Application (2015-2020)
Table 79. India Latanoprost Sales Market Share by Application (2015-2020)
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Latanoprost Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Pfizer Latanoprost Product
Table 84. Pfizer Recent Development
Table 85. Mylan Corporation Information
Table 86. Mylan Description and Business Overview
Table 87. Mylan Latanoprost Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Mylan Latanoprost Product
Table 89. Mylan Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Latanoprost Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Novartis Latanoprost Product
Table 94. Novartis Recent Development
Table 95. Apotex Corporation Information
Table 96. Apotex Description and Business Overview
Table 97. Apotex Latanoprost Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Apotex Latanoprost Product
Table 99. Apotex Recent Development
Table 100. Teva Corporation Information
Table 101. Teva Description and Business Overview
Table 102. Teva Latanoprost Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Teva Latanoprost Product
Table 104. Teva Recent Development
Table 105. Taj Pharma Corporation Information
Table 106. Taj Pharma Description and Business Overview
Table 107. Taj Pharma Latanoprost Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Taj Pharma Latanoprost Product
Table 109. Taj Pharma Recent Development
Table . CR Zizhu Corporation Information
Table . CR Zizhu Description and Business Overview
Table . CR Zizhu Latanoprost Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . CR Zizhu Latanoprost Product
Table . CR Zizhu Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Latanoprost Distributors List
Table 118. Latanoprost Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Latanoprost Product Picture
Figure 2. Global Latanoprost Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Latanoprost Market Share by Application in 2020 & 2026
Figure 6. Open-angle Glaucoma Examples
Figure 7. Close-angle Glaucoma Examples
Figure 8. Global Latanoprost Sales (M Unit) Growth Rate (2015-2026)
Figure 9. Global Latanoprost Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Latanoprost Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Latanoprost Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Latanoprost Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Latanoprost Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Latanoprost Sales (M Unit) Growth Rate (2015-2026)
Figure 15. Europe Latanoprost Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Latanoprost Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Latanoprost Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Latanoprost Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Latanoprost Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Latanoprost Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Latanoprost Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Latanoprost Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Latanoprost Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Latanoprost Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Latanoprost Players Market Share by Revenue in Latanoprost 2015 & 2019
Figure 26. Latanoprost Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Latanoprost Revenue Share by Type (2015-2020)
Figure 28. Global Latanoprost Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Latanoprost Revenue Share by Application (2015-2020)
Figure 30. Global Latanoprost Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Latanoprost Sales Market Share by Type in 2019
Figure 32. United States Latanoprost Sales Market Share by Type in 2019
Figure 33. Europe Latanoprost Sales Market Share by Company in 2019
Figure 34. Europe Latanoprost Sales Market Share by Type in 2019
Figure 35. Europe Latanoprost Sales Market Share by Application in 2019
Figure 36. China Latanoprost Sales Market Share by Company in 2019
Figure 37. China Latanoprost Sales Market Share by Type in 2019
Figure 38. China Latanoprost Sales Market Share by Application in 2019
Figure 39. Japan Latanoprost Sales Market Share by Company in 2019
Figure 40. Japan Latanoprost Sales Market Share by Type in 2019
Figure 41. Japan Latanoprost Sales Market Share by Application in 2019
Figure 42. Southeast Asia Latanoprost Sales Market Share by Company in 2019
Figure 43. Southeast Asia Latanoprost Sales Market Share by Type in 2019
Figure 44. Southeast Asia Latanoprost Sales Market Share by Application in 2019
Figure 45. India Latanoprost Sales Market Share by Company in 2019
Figure 46. India Latanoprost Sales Market Share by Type in 2019
Figure 47. India Latanoprost Sales Market Share by Application in 2019
Figure 48. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Taj Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. CR Zizhu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Latanoprost
Figure 57. Manufacturing Process Analysis of Latanoprost
Figure 58. Latanoprost Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
微小侵襲性緑内障手術器具の世界市場レポート2020 Market Analysis and Insights: Global Micro-Invasive Glaucoma Surgery Devices Market The global Micro-Invasive Glaucoma Surgery Devices market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Micro-Invasive Glauco…- 緑内障治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Glaucoma Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glaucoma Medications mar…
- 緑内障ドレナージバルブの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Glaucoma Drainage Valve market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glaucoma Drainage Val…
- 二重角度フライスの世界市場レポート2020 Double angle mill cutters have two tapered surfaces along the peripheral cutting edge that come to a point. Market Analysis and Insights: Global Double-Angle Milling Cutter Market The global Double-Angle Milling Cutter market was valued at US$ xx million in 2019 and will reach US$ xx million by the …
- 緑内障手術デバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Glaucoma Surgery Device market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glaucoma Surgery Devi…